Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target
  • Published Date:
    August 24 2018
  • Source:
    Cancer Lett. 437:1-12
  • Language:
Filetype[PDF-2.91 MB]

No Related Documents.
You May Also Like: